Hannia Mendoza-Dickey Joins Cannabis Science and Technology’s Editorial Advisory Board
Cannabis Science and Technology is pleased to announce the addition of Hannia Mendoza-Dickey to its Editorial Advisory Board.
Advancements in Cannabis Research: Insights from Healer’s July 2024 Webinar
This month’s webinar discussed studies conducted on cannabis and psychedelics for various conditions including anxiety and autism spectrum disorder.
2024 Mid-Year Cannabis Content Roundup
Check out some of our most popular content from the first six months of the year 2024!
Complexities of the Hemp Industry Today: A Webinar from the GMP Collective
This latest episode of the monthly webinar series untangled the various aspects currently facing the US hemp industry.
CBD vs. THC: Exploring the Differences and Potential Benefits
Here, Scott Mazza, Founder of Vitality CBD, compares the effects of the cannabis compounds CBD and THC for use with various conditions.
Medical Cannabis Passes North Carolina Senate
The Senate’s latest attempt at legal medical cannabis access for patients was added to a bill on hemp regulations.
June 2024 Webinar Coverage Round Up
Let’s take a look at the most recent webinars on cannabis research and medicine to catch up on industry trends and innovations.
Thousands of Cannabis Convictions Pardoned in Maryland
An executive order from the governor pardoned a significant number of cannabis convictions, noting the efforts to rectify harms from past cannabis policies.
Comprehensive Profiling of Illegal Cannabis: A GC-MS Approach to Assist in Classification of Samples
This article, originally published by our sister brand LCGC International, summarizes an analysis and profiling of samples of illegal cannabis crops in Messina, Italy.
DaySavers Partners with Leading Cannabis Research Organizations for Comprehensive Study on Smokability
The smoking accessories company has partnered with the Science of Smokability study to advance research on cannabis smoking quality and consistency.
Cannabis and Dementia Symptoms: Healer Webinar Examines Relevant Research
This month’s Healer webinar discussed several studies on cannabis and symptoms of dementia and cognitive decline.
Exploring the Research on THC and D-Limonene: A Presentation from Ethan Russo, MD
This webinar discussed the research on the synergy of THC and D-limonene, discussing a study that found vaporized D-limonene reduces THC-induced anxiety.
Nebraska Approaches Deadline to Include Medical Cannabis on November Ballot
Nebraska advocates are a few weeks away from knowing if two medical cannabis measures have enough signatures to qualify to appear on the 2024 ballot.
New York Governor Appoints New Office of Cannabis Management Leadership
Three new positions were created to streamline and improve licensing processes, social equity, and more.
Washington State Tax Exemption Takes Effect for Medical Cannabis Patients
The new law eliminates the 37% excise tax for medical cannabis cardholders for certain products.
Willow Industries Announces Partnership with the Cannabis Research Coalition
Willow Industries recently partnered with the Cannabis Research Coalition to advance cannabis research.
Recreational Cannabis Will Be on South Dakota’s November Ballot
For the third time in recent years, the option to legalize recreational cannabis will be placed before voters in the Mount Rushmore State.
Cannabis Possession and Private Cultivation Legalized in South Africa
The Cannabis for Private Purposes Act legalizes cannabis for adults while prohibiting public consumption, sales, and detailing measures for protecting children.
Amendment to 2024 Farm Bill Draft Would Affect Intoxicating Hemp-Derived Products
A recently added amendment to the 2024 Farm Bill would significantly impact intoxicating hemp-derived products.
Insights and Achievements in Cannabis Science: Dr. Ethan Russo Discusses Dr. Raphael Mechoulam's Legacy
This webinar from MM411 explored the far-ranging studies of Dr. Raphael Mechoulam and Dr. Ethan Russo on the science and medicine of cannabis and other plants.
Cannabis Lab Shopping: Causes, Effects, and Solutions from a GMP Webinar
The latest webinar from the GMP Collective discussed the practice of lab shopping and the various causes, effects, and potential solutions.
S3 Collective Announces Acceptance into FDA’s Network of Experts Program
The nonprofit, which is focused on advancing the cannabis industry, joins a network of industry experts from over a hundred different organizations.
Cannabis for Harm Reduction: Recommendations for Future Policies
The final installment of this webinar series discussed recommendations for new policies integrating cannabis into harm reduction efforts.
Protecting Consumers: Enhancing CBD Product Safety Through Proactive Standards and Regulations
At the Cannabis Science Conference Spring 2024, toxicologist Cristelle Santos provided a deep dive into the need for better cannabis product safety standards.
Challenges and Opportunities in (Inter)National Cannabis and Hemp Regulations: Perspectives from A GMP Webinar
This hour-long webinar covered consumer safety, interstate commerce, and the need for global standards, highlighting collaboration and evidence-based approaches for future regulatory frameworks.
Cannabis Science Conference Spring 2024 Highlights Compilation
Here we present a roundup of the interviews, insights, and presentation coverage from both before and during this year’s conference in Kansas City, Missouri from May 7-9, 2024.
Real-Time Cannabis Cultivation Insights: An Interview with James Wylde at Cannabis Science Conference 2024
In this interview at the Cannabis Science Conference, James Wylde, President and CEO of Greenlight Analytical, discusses new cannabis cultivation tools.
Navigating the Future of Medical Cannabis: Insights from Americans for Safe Access on the Cannabis Rescheduling Proposal
Focusing on the potential effects for medical cannabis patients, Americans for Safe Access held a high-level presentation and discussion on the rescheduling of cannabis.
US Justice Department Submits Proposal to Potentially Reclassify Cannabis
The US Attorney General has initiated the process to reclassify cannabis from a Schedule I to a less-restrictive Schedule III substance.
Cannabis Cultivation Dynamics and Terpene Yield: Research Insights from Antonio Timoteo Jr., PhD
At the Cannabis Science Conference, Antonio Timoteo Jr., PhD, presented research on cannabis cultivation practices and optimizing terpene content.